globe aesthetic and medical technologies limited
globe aesthetic and medical technologies limited Company Information
Company Number
02611941
Next Accounts
Dec 2025
Directors
Shareholders
globe microsystems ltd
Group Structure
View All
Industry
Installation of industrial machinery and equipment
+1Registered Address
unit e unit e, argent court, hook rise south, surbiton, KT6 7NL
Website
www.globemicro.comglobe aesthetic and medical technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED at £173.1k based on a Turnover of £377.2k and 0.46x industry multiple (adjusted for size and gross margin).
globe aesthetic and medical technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED at £0 based on an EBITDA of £-69 and a 3.55x industry multiple (adjusted for size and gross margin).
globe aesthetic and medical technologies limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED at £0 based on Net Assets of £-134.1k and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Globe Aesthetic And Medical Technologies Limited Overview
Globe Aesthetic And Medical Technologies Limited is a live company located in surbiton, KT6 7NL with a Companies House number of 02611941. It operates in the installation of industrial machinery and equipment sector, SIC Code 33200. Founded in May 1991, it's largest shareholder is globe microsystems ltd with a 100% stake. Globe Aesthetic And Medical Technologies Limited is a mature, micro sized company, Pomanda has estimated its turnover at £377.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Globe Aesthetic And Medical Technologies Limited Health Check
Pomanda's financial health check has awarded Globe Aesthetic And Medical Technologies Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
8 Weak
Size
annual sales of £377.2k, make it smaller than the average company (£9.2m)
- Globe Aesthetic And Medical Technologies Limited
£9.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (10%)
- Globe Aesthetic And Medical Technologies Limited
10% - Industry AVG
Production
with a gross margin of 21.3%, this company has a higher cost of product (38.7%)
- Globe Aesthetic And Medical Technologies Limited
38.7% - Industry AVG
Profitability
an operating margin of 0% make it less profitable than the average company (4.4%)
- Globe Aesthetic And Medical Technologies Limited
4.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (39)
- Globe Aesthetic And Medical Technologies Limited
39 - Industry AVG
Pay Structure
on an average salary of £63.1k, the company has an equivalent pay structure (£63.1k)
- Globe Aesthetic And Medical Technologies Limited
£63.1k - Industry AVG
Efficiency
resulting in sales per employee of £188.6k, this is equally as efficient (£192.2k)
- Globe Aesthetic And Medical Technologies Limited
£192.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Globe Aesthetic And Medical Technologies Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 221 days, this is slower than average (36 days)
- Globe Aesthetic And Medical Technologies Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 52 days, this is more than average (26 days)
- Globe Aesthetic And Medical Technologies Limited
26 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (12 weeks)
0 weeks - Globe Aesthetic And Medical Technologies Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 390.5%, this is a higher level of debt than the average (60.9%)
390.5% - Globe Aesthetic And Medical Technologies Limited
60.9% - Industry AVG
GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED financials
Globe Aesthetic And Medical Technologies Limited's latest turnover from March 2024 is estimated at £377.2 thousand and the company has net assets of -£134.1 thousand. According to their latest financial statements, we estimate that Globe Aesthetic And Medical Technologies Limited has 2 employees and maintains cash reserves of £862 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 521,112 | |||||||||||||||
| Other Income Or Grants | ||||||||||||||||
| Cost Of Sales | 318,521 | |||||||||||||||
| Gross Profit | 202,591 | |||||||||||||||
| Admin Expenses | 150,608 | |||||||||||||||
| Operating Profit | 51,983 | |||||||||||||||
| Interest Payable | ||||||||||||||||
| Interest Receivable | 3,183 | |||||||||||||||
| Pre-Tax Profit | 56,415 | |||||||||||||||
| Tax | -11,426 | |||||||||||||||
| Profit After Tax | 44,989 | |||||||||||||||
| Dividends Paid | 40,000 | |||||||||||||||
| Retained Profit | 4,989 | |||||||||||||||
| Employee Costs | ||||||||||||||||
| Number Of Employees | ||||||||||||||||
| EBITDA* | 52,608 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,734 | 2,734 | 6,734 | 10,786 | 15,447 | 20,108 | 25,637 | 20,559 | 661 | 1,157 | ||||||
| Intangible Assets | ||||||||||||||||
| Investments & Other | ||||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||||
| Total Fixed Assets | 2,734 | 2,734 | 6,734 | 10,786 | 15,447 | 20,108 | 25,637 | 20,559 | 661 | 1,157 | ||||||
| Stock & work in progress | 42,565 | 42,565 | 42,565 | 42,565 | 37,989 | 38,005 | 40,468 | 36,560 | 42,009 | |||||||
| Trade Debtors | 364 | 207,595 | 98,771 | |||||||||||||
| Group Debtors | ||||||||||||||||
| Misc Debtors | 3,554 | |||||||||||||||
| Cash | 862 | 1,791 | 4,913 | 5,209 | 5,995 | 15,289 | 1,897 | 42,558 | 778 | 102,872 | 212,258 | |||||
| misc current assets | ||||||||||||||||
| total current assets | 43,427 | 44,356 | 47,478 | 47,774 | 44,348 | 53,294 | 42,365 | 79,118 | 42,787 | 310,467 | 314,583 | |||||
| total assets | 46,161 | 47,090 | 54,212 | 58,560 | 59,795 | 73,402 | 68,002 | 99,677 | 42,787 | 311,128 | 315,740 | |||||
| Bank overdraft | 84,777 | |||||||||||||||
| Bank loan | ||||||||||||||||
| Trade Creditors | 180,264 | 181,193 | 177,499 | 197,082 | 207,973 | 222,453 | 26,092 | 25,239 | 52,731 | 48,056 | 48,056 | 48,056 | 48,056 | 48,056 | 121,560 | 98,991 |
| Group/Directors Accounts | ||||||||||||||||
| other short term finances | ||||||||||||||||
| hp & lease commitments | ||||||||||||||||
| other current liabilities | 10,773 | 10,777 | 204,494 | 258,974 | 97,616 | 19,432 | ||||||||||
| total current liabilities | 180,264 | 181,193 | 188,272 | 207,859 | 207,973 | 228,305 | 230,586 | 284,213 | 150,347 | 48,056 | 48,056 | 48,056 | 48,056 | 48,056 | 121,560 | 203,200 |
| loans | ||||||||||||||||
| hp & lease commitments | ||||||||||||||||
| Accruals and Deferred Income | ||||||||||||||||
| other liabilities | ||||||||||||||||
| provisions | ||||||||||||||||
| total long term liabilities | ||||||||||||||||
| total liabilities | 180,264 | 181,193 | 188,272 | 207,859 | 207,973 | 228,305 | 230,586 | 284,213 | 150,347 | 48,056 | 48,056 | 48,056 | 48,056 | 48,056 | 121,560 | 203,200 |
| net assets | -134,103 | -134,103 | -134,060 | -149,299 | -148,178 | -154,903 | -162,584 | -184,536 | -107,560 | -48,056 | -48,056 | -48,056 | -48,056 | -48,056 | 189,568 | 112,540 |
| total shareholders funds | -134,103 | -134,103 | -134,060 | -149,299 | -148,178 | -154,903 | -162,584 | -184,536 | -107,560 | -48,056 | -48,056 | -48,056 | -48,056 | -48,056 | 189,568 | 112,540 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Profit | 51,983 | |||||||||||||||
| Depreciation | 4,000 | 4,052 | 4,661 | 4,661 | 5,529 | 5,212 | 4,970 | 661 | 625 | |||||||
| Amortisation | ||||||||||||||||
| Tax | -11,426 | |||||||||||||||
| Stock | 4,576 | -16 | -2,463 | 3,908 | -5,449 | 42,009 | ||||||||||
| Debtors | -364 | 364 | -207,595 | 105,270 | 102,325 | |||||||||||
| Creditors | -929 | 3,694 | -19,583 | -10,891 | -14,480 | 196,361 | 853 | -27,492 | 4,675 | -73,504 | 22,569 | 98,991 | ||||
| Accruals and Deferred Income | -10,773 | -4 | 10,777 | -204,494 | -54,480 | 161,358 | 97,616 | -19,432 | 19,432 | |||||||
| Deferred Taxes & Provisions | ||||||||||||||||
| Cash flow from operations | 57,280 | |||||||||||||||
| Investing Activities | ||||||||||||||||
| capital expenditure | ||||||||||||||||
| Change in Investments | ||||||||||||||||
| cash flow from investments | ||||||||||||||||
| Financing Activities | ||||||||||||||||
| Bank loans | ||||||||||||||||
| Group/Directors Accounts | ||||||||||||||||
| Other Short Term Loans | ||||||||||||||||
| Long term loans | ||||||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||||
| other long term liabilities | ||||||||||||||||
| share issue | ||||||||||||||||
| interest | 3,183 | |||||||||||||||
| cash flow from financing | 110,734 | |||||||||||||||
| cash and cash equivalents | ||||||||||||||||
| cash | -929 | -3,122 | -296 | -786 | -9,294 | 13,392 | -40,661 | 41,780 | 778 | -102,872 | -109,386 | 212,258 | ||||
| overdraft | -84,777 | 84,777 | ||||||||||||||
| change in cash | -929 | -3,122 | -296 | -786 | -9,294 | 13,392 | -40,661 | 41,780 | 778 | -102,872 | -24,609 | 127,481 |
globe aesthetic and medical technologies limited Credit Report and Business Information
Globe Aesthetic And Medical Technologies Limited Competitor Analysis
Perform a competitor analysis for globe aesthetic and medical technologies limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in KT6 area or any other competitors across 12 key performance metrics.
globe aesthetic and medical technologies limited Ownership
GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED group structure
Globe Aesthetic And Medical Technologies Limited has no subsidiary companies.
Ultimate parent company
2 parents
GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED
02611941
globe aesthetic and medical technologies limited directors
Globe Aesthetic And Medical Technologies Limited currently has 1 director, Mr Lucien Bartram serving since Feb 2011.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Lucien Bartram | England | 59 years | Feb 2011 | - | Director |
P&L
March 2024turnover
377.2k
+10%
operating profit
-69.6
0%
gross margin
21.4%
-1.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-134.1k
0%
total assets
46.2k
-0.02%
cash
862
-0.52%
net assets
Total assets minus all liabilities
Similar Companies
globe aesthetic and medical technologies limited company details
company number
02611941
Type
Private limited with Share Capital
industry
33200 - Installation of industrial machinery and equipment
62090 - Other information technology and computer service activities
incorporation date
May 1991
age
34
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
March 2024
previous names
globe aesthetic and medical technology limited (June 2015)
bonitas limited (June 2015)
accountant
-
auditor
-
address
unit e unit e, argent court, hook rise south, surbiton, KT6 7NL
Bank
-
Legal Advisor
-
globe aesthetic and medical technologies limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to globe aesthetic and medical technologies limited.
globe aesthetic and medical technologies limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLOBE AESTHETIC AND MEDICAL TECHNOLOGIES LIMITED. This can take several minutes, an email will notify you when this has completed.
globe aesthetic and medical technologies limited Companies House Filings - See Documents
| date | description | view/download |
|---|
